HRS Investment Holdings LLC grew its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 30.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 42,500 shares of the pharmacy operator’s stock after acquiring an additional 10,000 shares during the period. Walgreens Boots Alliance comprises approximately 1.3% of HRS Investment Holdings LLC’s holdings, making the stock its 16th biggest holding. HRS Investment Holdings LLC’s holdings in Walgreens Boots Alliance were worth $2,551,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. BlueMountain Capital Management LLC acquired a new stake in Walgreens Boots Alliance during the 2nd quarter valued at $103,000. CSat Investment Advisory L.P. acquired a new stake in Walgreens Boots Alliance during the 2nd quarter valued at $104,000. Squar Milner Financial Services LLC acquired a new stake in Walgreens Boots Alliance during the 2nd quarter valued at $106,000. Archford Capital Strategies LLC acquired a new stake in Walgreens Boots Alliance during the 1st quarter valued at $115,000. Finally, Kaizen Advisory LLC grew its holdings in Walgreens Boots Alliance by 128.6% during the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock valued at $116,000 after purchasing an additional 1,083 shares in the last quarter. 61.99% of the stock is currently owned by institutional investors and hedge funds.
Shares of WBA stock opened at $67.77 on Friday. The firm has a market cap of $67.72 billion, a price-to-earnings ratio of 13.29, a P/E/G ratio of 1.04 and a beta of 1.09. The company has a quick ratio of 0.47, a current ratio of 0.93 and a debt-to-equity ratio of 0.44. Walgreens Boots Alliance Inc has a 1-year low of $59.07 and a 1-year high of $83.89.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 28th. The pharmacy operator reported $1.53 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.47 by $0.06. The company had revenue of $34.33 billion during the quarter, compared to analyst estimates of $34.15 billion. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. The firm’s revenue for the quarter was up 14.0% compared to the same quarter last year. During the same period last year, the business earned $1.33 EPS. equities analysts forecast that Walgreens Boots Alliance Inc will post 5.97 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 12th. Shareholders of record on Monday, August 20th will be issued a dividend of $0.44 per share. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.40. This represents a $1.76 annualized dividend and a yield of 2.60%. The ex-dividend date of this dividend is Friday, August 17th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 34.51%.
In other news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction dated Thursday, August 2nd. The shares were sold at an average price of $65.99, for a total value of $180,548.64. Following the transaction, the director now directly owns 10,943 shares in the company, valued at approximately $722,128.57. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Ornella Barra purchased 1,700,000 shares of Walgreens Boots Alliance stock in a transaction dated Monday, July 16th. The stock was acquired at an average price of $65.15 per share, for a total transaction of $110,755,000.00. The disclosure for this purchase can be found here. 14.80% of the stock is owned by company insiders.
A number of equities research analysts recently weighed in on WBA shares. ValuEngine lowered shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Tuesday, May 22nd. Leerink Swann lowered their price target on shares of Walgreens Boots Alliance from $75.00 to $70.00 and set a “market perform” rating for the company in a report on Wednesday, May 23rd. Mizuho set a $77.00 price target on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a report on Tuesday, May 29th. BidaskClub lowered shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Tuesday, June 5th. Finally, Zacks Investment Research raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $72.00 price target for the company in a report on Tuesday, June 19th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Walgreens Boots Alliance has an average rating of “Hold” and an average target price of $77.22.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Further Reading: Dividend Stocks – Are They Right For You?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.